Published in Genetics on March 02, 2005
alpha-Synuclein and neuronal cell death. Mol Neurodegener (2009) 1.85
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener (2012) 1.63
Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell (2008) 1.48
Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J Mol Biol (2006) 1.47
YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation. J Cell Biol (2007) 1.00
Protein aggregation and polyasparagine-mediated cellular toxicity in Saccharomyces cerevisiae. Prion (2007) 0.95
Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease. PLoS One (2011) 0.94
Novel suppressors of alpha-synuclein toxicity identified using yeast. Hum Mol Genet (2008) 0.94
NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins. Hum Mol Genet (2013) 0.91
Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease. Proc Natl Acad Sci U S A (2014) 0.86
Methionine oxidation of Sup35 protein induces formation of the [PSI+] prion in a yeast peroxiredoxin mutant. J Biol Chem (2011) 0.85
Translocation of alpha-synuclein expressed in Escherichia coli. J Bacteriol (2007) 0.84
Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation. Cell Stress Chaperones (2009) 0.84
Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome. J Biol Chem (2012) 0.84
Contribution of Alanine-76 and Serine Phosphorylation in α-Synuclein Membrane Association and Aggregation in Yeasts. Parkinsons Dis (2011) 0.84
Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner. PLoS One (2010) 0.83
Gender differences in Parkinson's disease: focus on plasma α-synuclein. J Neural Transm (Vienna) (2013) 0.82
A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration. PLoS One (2013) 0.81
Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegener (2013) 0.81
Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy. Clin Dev Immunol (2013) 0.81
The benefits of humanized yeast models to study Parkinson's disease. Oxid Med Cell Longev (2013) 0.80
Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways. Mol Neurobiol (2015) 0.78
Contribution of yeast models to neurodegeneration research. J Biomed Biotechnol (2012) 0.78
Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast. Biomolecules (2015) 0.77
Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins. Front Mol Neurosci (2015) 0.77
Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity. Proc Natl Acad Sci U S A (2014) 0.76
C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. PLoS Genet (2016) 0.76
From the baker to the bedside: yeast models of Parkinson's disease. Microb Cell (2015) 0.75
Familial Parkinson's Disease Mutant E46K α-Synuclein Localizes to Membranous Structures, Forms Aggregates, and Induces Toxicity in Yeast Models. ISRN Neurol (2011) 0.75
The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy. Neural Plast (2017) 0.75
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell (1980) 23.17
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Mechanisms of intracellular protein transport. Nature (1994) 13.54
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Impairment of the ubiquitin-proteasome system by protein aggregation. Science (2001) 11.51
COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell (1994) 10.01
A Drosophila model of Parkinson's disease. Nature (2000) 7.82
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry (1996) 6.47
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (2000) 6.28
A simple and efficient procedure for transformation of yeasts. Biotechniques (1992) 6.08
Toxic proteins in neurodegenerative disease. Science (2002) 5.82
Vesicle fusion from yeast to man. Nature (1994) 4.71
Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast. Yeast (1993) 4.68
Sec9 is a SNAP-25-like component of a yeast SNARE complex that may be the effector of Sec4 function in exocytosis. Cell (1994) 4.46
Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science (2003) 4.45
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci (1988) 4.36
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (2001) 4.18
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci (2002) 4.01
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A (2000) 3.82
The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J Cell Biol (1989) 3.55
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron (1995) 3.37
A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol (2003) 2.97
A broken alpha -helix in folded alpha -Synuclein. J Biol Chem (2003) 2.80
PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J Biol Chem (1993) 2.71
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J Biol Chem (2001) 2.49
Yeast homologues of tomosyn and lethal giant larvae function in exocytosis and are associated with the plasma membrane SNARE, Sec9. J Cell Biol (1999) 2.33
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem (1998) 2.32
Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J Biol Chem (2002) 2.19
Understanding cell death in Parkinson's disease. Ann Neurol (1998) 2.16
Neuropathology in mice expressing human alpha-synuclein. J Neurosci (2000) 2.06
Animal models of Parkinson's disease. Bioessays (2002) 2.05
Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell (1997) 1.91
Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem (2004) 1.84
Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry (2004) 1.77
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74
Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J Biol Chem (2000) 1.72
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry (2004) 1.71
The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsf1 in vivo and is required for the induction of heat shock genes by oxidative stress. Mol Biol Cell (2000) 1.69
Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. J Mol Neurosci (2004) 1.63
Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci (2000) 1.63
Altered transcription in yeast expressing expanded polyglutamine. Proc Natl Acad Sci U S A (2001) 1.58
A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum. J Biol Chem (1999) 1.56
Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J Mol Biol (2002) 1.52
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis (2001) 1.48
Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev (2003) 1.41
Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol (2002) 1.39
Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol (1996) 1.35
Basal-level expression of the yeast HSP82 gene requires a heat shock regulatory element. Mol Cell Biol (1989) 1.33
Plasma membrane localization of the Yck2p yeast casein kinase 1 isoform requires the C-terminal extension and secretory pathway function. J Cell Sci (2002) 1.24
Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport (2002) 1.15
A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. Eur J Biochem (2002) 1.03
Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol Cells (1997) 1.03
Dynamic chromatin alterations triggered by natural and synthetic activation domains. J Biol Chem (2002) 1.01
Overproduction of polypeptides corresponding to the amino terminus of the F-box proteins Cdc4p and Met30p inhibits ubiquitin ligase activities of their SCF complexes. Eukaryot Cell (2003) 0.88
Protein folding. The difference with prokaryotes. Nature (1997) 0.88
Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol (2001) 0.81
Autosomal dominant Parkinson's disease. J Neurol (1998) 0.77
Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther (2005) 2.02
Domain-wide displacement of histones by activated heat shock factor occurs independently of Swi/Snf and is not correlated with RNA polymerase II density. Mol Cell Biol (2005) 1.89
Epigenetic silencing mechanisms in budding yeast and fruit fly: different paths, same destinations. Mol Cell (2005) 1.73
Sir2 silences gene transcription by targeting the transition between RNA polymerase II initiation and elongation. Mol Cell Biol (2008) 1.12
A functional module of yeast mediator that governs the dynamic range of heat-shock gene expression. Genetics (2006) 1.04
Destabilization of binding to cofactors and SCFMet30 is the rate-limiting regulatory step in degradation of polyubiquitinated Met4. Mol Cell (2006) 1.01
Dynamic chromatin alterations triggered by natural and synthetic activation domains. J Biol Chem (2002) 1.01
SAGA and Rpd3 chromatin modification complexes dynamically regulate heat shock gene structure and expression. J Biol Chem (2009) 0.96
Mediator recruitment to heat shock genes requires dual Hsf1 activation domains and mediator tail subunits Med15 and Med16. J Biol Chem (2013) 0.95
Role of Mediator in regulating Pol II elongation and nucleosome displacement in Saccharomyces cerevisiae. Genetics (2012) 0.94
Overproduction of polypeptides corresponding to the amino terminus of the F-box proteins Cdc4p and Met30p inhibits ubiquitin ligase activities of their SCF complexes. Eukaryot Cell (2003) 0.88
Using genomics and proteomics to investigate mechanisms of transcriptional silencing in Saccharomyces cerevisiae. Brief Funct Genomic Proteomic (2006) 0.80
Identification of residues in the WD-40 repeat motif of the F-box protein Met30p required for interaction with its substrate Met4p. Mol Genet Genomics (2005) 0.80
p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo. PLoS One (2011) 0.79
Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response. Exp Neurol (2010) 0.79
The amino-terminal portion of the F-box protein Met30p mediates its nuclear import and assimilation into an SCF complex. J Biol Chem (2003) 0.77
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 0.75
Gene Control during Transcription Elongation. Genet Res Int (2012) 0.75